President-elect Donald Trump tapped Robert F. Kennedy Jr on November 14, 2024, to be Secretary of Health and Human Services. Considering his anti-vaccine and other contentious public health opinions, questions arising surrounding Medicare, Medicaid and the future of healthcare in America can be considered. Radical change may be expected from how healthcare policies would be constructed and carried out during his leadership.
About Robert F. Kennedy Jr.
Once respected for his service as a respected environmental attorney and a member of the Kennedy political dynasty, Robert F. Kennedy Jr has become infamous for spreading anti-vaccine propaganda. He has skeptically trended in areas regarding the promotion of disproven theories that link vaccines to autism, full in conflict with overwhelming scientific evidence to the contrary. Kennedy founded the organization Children’s Health Defense, which operates based on the mandates against vaccines and promotes vaccine misinformation.
As secretary of HHS, Kennedy will lead an agency governing key healthcare programs that consist of Medicare and Medicaid, serving millions of Americans. Given his background of challenging conventional wisdom in public health, under his stewardship, these programs may change greatly.
Changes to Medicare and Medicaid
Secretary of HHS, Kennedy will be in charge of the Centers for Medicare & Medicaid Services, which takes care of the administration of both programs. A course of action he adopts regarding this matter is likely to attract a host of potential alterations:
- Policy direction: Kennedy may want to shift the focus from infectious diseases to chronic ones like obesity and diabetes. For this, he might introduce new programs of their prevention and management within the Medicare and Medicaid framework.
- Coverage decisions: Changes in coverage decisions for treatments and drugs could be well-backed and pushed by Kennedy in these programs. As an ardent critic of pharmaceutical companies, drug approval processes and coverage decisions will be subjected to harsh scrutiny, and possibly limit medications already covered.
- Appropriation of funds: The seriousness with which Kennedy addresses health agencies about the adoption of accountability and transparency might shine through in reform in the appropriateness of funds; this could be in Medicare or Medicaid. This could include the shift of resources to preventive care and alternative therapies lines with his general principle of health.
More general implications for healthcare
The Kennedy appointment might presage a new era in U.S. health policy, whose ripples may spread quite far:
- Vaccine policy shifts: Much has been written about Kennedy’s opposition to vaccines. At least some have expressed concern that Kennedy might attempt to shift either the ways vaccines are distributed or how vaccination programs are funded at HHS. This, of course, would have potential backlash with public health efforts at disease control, particularly in low-income children dependent on vaccination programs provided by the government.
- Regulatory overhaul: Kennedy has said he will tear down what he called the bureaucratic inefficiencies within HHS. That also means taking aim at personnel he views as a block to him and his agenda, perhaps disrupting ongoing efforts in public health and research that currently take place within agencies like NIH and the CDC.
- Food and drug safety: Kennedy’s controls over the food safety legislation and pharmaceutical laws would face much scrutiny. He earlier pressed to ban certain additives in food products and to restrict the influence of pharmaceutical companies on regulatory procedures; changes that could drastically affect how drugs are cleared and monitored.
Challenges ahead
The only thing not quite straightforward, in fact, about Kennedy’s nomination is that he will have to be confirmed by the Senate in the face of an overwhelming outcry from public health groups who are deeply fearful that his leadership would undermine decades of progress in vaccine safety and public health policy. Some critics expressed that putting an individual with a record of spreading misinformation into a position of great power and influence poses a danger to national efforts aimed at protecting the nation’s most vulnerable populations in health.
Although Trump has promised Kennedy significant leeway in how health policies will be implemented, the complexity of federal regulations will ensure that major changes get caught up in bureaucratic red tape. Experts say even if Kennedy tries to change the policies, entrenched agencies like the FDA and CDC may refuse to change their guidelines since they often base their policies on scientific evidence.
Read more: Who will win the US election? This is what the latest polls say between Trump vs Harris with one week to go before November…
Read more: Elon Musk is offering $1 million a day to voters who register in swing states (despite DOJ warning) – Here are the Super PAC’s…
